HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Shao, C. Articles by Ma, J.-x. Search for Related Content PubMed PubMed Citation Articles by Shao, C. Articles by Ma, J.-x.

Suppression of Corneal Neovascularization by PEDF Release from Human Amniotic Membranes

¹From the Department of Medicine, Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; ²The Third Hospital, Zhongshan University, Guangzhou, China; the ³Department of Ophthalmology, The Jinhua Central Hospital, Zhejiang, China; and the ⁴Department of Biological Science, College of Optometry, State University of New York, New York City, New York.

PURPOSE. Human amniotic membrane (HAM) transplantation is commonly used in corneal surface reconstruction and is known to inhibit neovascularization of this tissue. The purpose of the present study is to reveal the molecular basis underlying antiangiogenic activity of HAM.

METHODS. The effects of HAM protein on proliferation of vascular endothelial cells and corneal epithelial cells were determined by quantifying viable cells using the MTT assay. The presence of pigment epithelium-derived factor (PEDF) in HAM was demonstrated at the protein level by Western blot analysis and immunohistochemistry using a monoclonal antibody specific to human PEDF. The PEDF concentration was measured by a specific ELISA. The expression of PEDF in HAM was confirmed at the RNA level by RT-PCR and DNA sequencing.

RESULTS. Soluble proteins from HAM inhibited proliferation of human umbilical vein endothelial cells and bovine retinal capillary endothelial cells (BRCECs) while promoting proliferation of bovine cornea epithelial cells. Moreover, the HAM-induced inhibition of BRCECs was neutralized by a specific anti-PEDF antibody. PEDF protein was identified with an abundance of 103.84 ± 33.21 ng/mg of soluble proteins, which is comparable to that in the retina, a PEDF-rich tissue. PEDF expression was predominantly localized in the basement membrane of HAM. RT-PCR using specific PEDF primers amplified a single product from HAM RNA. The PCR product has a sequence identical with that of human PEDF.

CONCLUSION. HAM specifically inhibits endothelial cell growth and thus suppresses neovascularization in the cornea. PEDF in HAM has a major role in eliciting this antiangiogenic activity.

This article has been cited by other articles:

				S. X Zhang, J. J Wang, G. Gao, K. Parke, and J.-x. Ma Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J. Mol. Endocrinol., August 1, 2006; 37(1): 1 - 12. [Abstract] [Full Text] [PDF]

				E. Sekiyama, T. Nakamura, L. J. Cooper, S. Kawasaki, J. Hamuro, N. J. Fullwood, and S. Kinoshita Unique distribution of thrombospondin-1 in human ocular surface epithelium. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1352 - 1358. [Abstract] [Full Text] [PDF]

				H. Li, J. Y. Niederkorn, S. Neelam, E. Mayhew, R. A. Word, J. P. McCulley, and H. Alizadeh Immunosuppressive Factors Secreted by Human Amniotic Epithelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 900 - 907. [Abstract] [Full Text] [PDF]